Sangamo Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.26

+0.01 (+5.35%)

As of Apr 1, 10:08 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 73%

Hold 3 27%

Sell 0 0%

Price Target

Analyst Price Target +7,700.8% upside

Low Target $11.90

Average Target $20.29

High Target $29.33

Current Price $0.26

Current
$0.26

Target
$20.29

$11.90 $20.29 avg $29.33

Scenario Analysis

Bear Case

$11.90

4,475.2%

Low target

Base Case

$20.29

+7,700.8%

Avg target

Bull Case

$29.33

+11,176.4%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$0.88

-70.4% from high

52-Week Low

$0.32

+-17.5% from low

Target vs 52W High

$20.29

+2,205.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%